Disclosed are antibodies specific for alpha-synuclein conformers and meth ods related thereto. For example, disclosed are methods of diagnosing a neur odegenerative such as Parkinson's disease, monitoring a neurodegenerative di sease progression, and monitoring a neurodegenerative disease treatment usin g the disclosed antibodies. Assays, kits, and solid supports related to alph a-synuclein and antibodies specific for alpha- synuclein are also disclosed.
ALPHA-SYNUCLEIN ANTIBODIES AND METHODS RELATED THERETO